PF-Atlas › Clinical Trials › NCT00087438

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

stereotactic body radiation therapy · Phase 2

Registry ID
NCT00087438
Phase
Phase 2
Status
Completed
Drug / intervention
stereotactic body radiation therapy
Sponsor
Radiation Therapy Oncology Group
Start
2004-05

About this trial

stereotactic body radiation therapy is evaluated in NCT00087438, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Radiation Therapy Oncology Group. Current status: Completed.

View NCT00087438 on ClinicalTrials.gov →

Explore related

All stereotactic body radiation therapy trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT00087438 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.